Lennard Lee | Associate Professor
University of Oxford

Lennard is an accomplished Oxford University cancer physician and national senior advisor for the cancer vaccine advance in the UK, and chief medical officer at the Ellison Institute of Technology. He is a research scene setter with a successful track record in delivering strategic national health mega projects. Combing academic expertise with effective project management and a strong background in healthcare, Lennard has made significant contributions in achieving projects for healthcare systems, industrial partners, government and those affected by cancer.   He an associate Professor at the University of Oxford where he is aligning strengths in vaccinology and cancer neoantigen prediction to lay the path to bespoke mRNA cancer vaccines. He has led of a number of flagship research programmes including the UK Covid cancer programme, he was the delivery lead for the NHS-Galleri study and the UK Lateral flow Moonshot. He has worked with the Office for Life Sciences as clinical advisor on the UK national cancer vaccine advance.   He has received numerous awards. This includes the UK government, Department of Science Innovation and Technology national superhero and the Government Science Infinity award award for his work in cancer vaccines, the National ACP McElwain Prize for work during the pandemic, and the IAP’s 21 Outstanding Young Physicians award. He has a strong track record of academic achievements, with nearly 100 publications in the highest impact journals, including the Lancet and JAMA.